Your Partner in MDI Development and Manufacturing

OzUK Limited, established in 2015, is a leading respiratory drug delivery company headquartered in Chippenham, UK, with a global presence and an office in Sydney, Australia. Our team of experts provides comprehensive solutions for the design, formulation, characterization, and study of inhalation products, with a particular focus on Metered Dose Inhalers (MDIs).

We specialize in all aspects of MDI development, from formulation research and design to manufacturing and characterization:

• Formulation development and optimization for MDI delivery
• Selection of propellants and valve design for optimal performance
• MDI-specific testing, including spray pattern anallysis, deposition studies, and in-vitro performance testing

Our Commitment Goes Beyond Technical Expertise

Our collaborative approach ensures we become an extension of your team, working alongside you to understand your specific needs and challenges. We are known for:

• Proactive problem-solving: We don't just identify issues; we work diligently to find effective solutions.
• Detailed approach: We take a meticulous approach to ensure every aspect of the MDI development process is carefully considered and optimized.
• Strong work ethic: Our team is dedicated to delivering high-quality work and meeting your project deadlines.

Trusted by Leading Companies

Here's what Valentino Parravicini, Chief Scientific Officer at Oxford Cannabinoid Technologies (OCT), has to say about their experience working with OzUK Limited:

Valentino Parravicini, Chief Scientific Officer, Oxford Cannabinoid Technologies (OCT):

“OzUK’s professional team, with vast expertise in inhalation, shaped and accelerated our development plan. They enabled us to meet quality and timeline goals, making them an integral part of our team.” 

Partner with OzUK Limited for Your Next MDI Project

OzUK Partners:

• Bespak
• H&T Presspart
• Ab Initio